Communicable Disease
11
2
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
18%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Challenge Non-Typhoidal Salmonella (CHANTS) Study
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
COVID-19 IgG Formation in Physicians at ALGH and Their Household Members
Prospective Urban Rural Epidemiology Study
Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe
A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety
ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19
COVID-19 Diagnostic Self-testing Using Virtual Point-of-care
Reducing Delay in Vaccination of Children: Logistic Barriers
Infection Detection by Breath Analysis
Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up